Due to sample size limitations, previous studies of DMARD use and COVID-19 outcomes have combined several different rheumatic diseases and medications, and investigated a single outcome—for example, the risk of hospitalization. ...
Jun 18, 2021
0
1
Rheumatoid arthritis (RA) is an inflammatory autoimmune disease that causes pain, swelling and stiffness in the joints. It can also cause fatigue, and the underlying inflammation may affect other body systems. Up to 10% of ...
Jun 18, 2021
0
1
The American College of Chest Physicians (CHEST) recently released new clinical guidelines on the Diagnosis and Evaluation of Hypersensitivity Pneumonitis (HP). The guidelines contain 14 evidence-based recommendations to ...
May 10, 2021
0
4
The U.S. Food and Drug Administration approved the first therapy in its class to reduce the frequency of bone marrow suppression induced by chemotherapy for extensive-stage small cell lung cancer, the agency announced Friday.
Feb 19, 2021
0
2
(HealthDay)—An inhaled medication might make every day physical activity a bit easier for patients with serious scarring of the lungs, a new clinical trial finds.
Jan 15, 2021
0
2
(HealthDay)—Inhaled treprostinil improves exercise capacity in patients with pulmonary hypertension due to interstitial lung disease, according to a study published online Jan. 13 in the New England Journal of Medicine.
Jan 14, 2021
0
8
The latest clinical practice guideline on home oxygen therapy addresses long-term and ambulatory oxygen therapy for adults with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) and includes ...
Nov 18, 2020
0
1
A new study shows that women with interstitial lung disease (ILD) related to autoimmune disease may not need to terminate their pregnancies—despite the increased risk of adverse outcomes—provided they have close monitoring ...
Nov 06, 2020
0
1
Autoimmune disease is fundamentally a mystery: whyever should an organism systematically set out to harm itself? Now, researchers at the University of Tsukuba have identified a genetic basis for anti-neutrophil cytoplasmic ...
Nov 04, 2020
0
2
More than 30 years after the last guidance on the clinical evaluation of hypersensitivity pneumonitis (HP), the American Thoracic Society—in collaboration with the Asociación Latinoamericana de Tórax or ALAT and the Japanese ...
Aug 03, 2020
0
1
Interstitial lung disease (ILD), also known as diffuse parenchymal lung disease (DPLD), refers to a group of lung diseases affecting the interstitium (the tissue and space around the air sacs of the lungs). It concerns alveolar epithelium, pulmonary capillary endothelium, basement membrane, perivascular and perilymphatic tissues.
The term ILD is used to distinguish these diseases from obstructive airways diseases.
Prolonged ILD may result in pulmonary fibrosis, but this is not always the case. Idiopathic pulmonary fibrosis is one form of "interstitial lung disease".
This text uses material from Wikipedia licensed under CC BY-SA
